Is BioNano Genomics Stock a Buy?
If you don't have an answer to this (large, open-ended, highly technical) question, don't worry: BioNano Genomics (NASDAQ: BNGO) might. As its name implies, the company makes laboratory equipment that helps researchers and clinicians answer a narrow subset of those thorny genomics questions. BioNano's Saphyr genome mapping device detects large structural variations and aberrations in chromosomes, which is something that standard gene sequencers can't do.